ZYDUSLIFE — Zydus Lifesciences Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual cashflow statement for Zydus Lifesciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	R2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	23,821	14,954	22,848	28,381	25,897
Depreciation
Non-Cash Items	657	7,681	5,070	-1,627	5,163
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-15,032	-4,546	-3,315	-13,333	-11,399
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	15,432	25,054	31,851	20,782	26,888
Capital Expenditures	-10,574	-9,041	-8,540	-12,026	-10,309
Purchase of Fixed Assets
Other Investing Cash Flow Items	-31,813	-1,082	1,315	23,570	22,021
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-42,387	-10,123	-7,225	11,544	11,712
Financing Cash Flow Items	-1,526	-287	-3,233	-1,111	-1,262
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	18,846	-10,942	-25,489	-8,683	-44,004
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-8,109	3,989	-905	23,729	-5,338